Moderna | MRNA - PE Price to Earnings



Moderna reported 27.22 in PE Price to Earnings for its fiscal quarter ending in June of 2023.


Pe Change Date
Acadia Pharmaceuticals 16.19 4.11 Jun/2025
Adcock Ingram Holdings 12.74 1.79 Jun/2024
Agios Pharmaceuticals 2.88 0.36 Jun/2025
Amgen 12.51 28.7 Jun/2025
Arrowhead Research 436.79 383.28 Jun/2020
Biogen 12.41 0.17 Jun/2025
BioMarin Pharmaceutical 15.13 7.26 Jun/2025
Celltrion 91.32 14.94 Mar/2025
Cspc Pharmaceutical 12.94 0.45 Mar/2025
Divis Laboratories Ltd 87.49 13.33 Jun/2025
Gilead Sciences 15.39 279.48 Jun/2025
GlaxoSmithKline GBP 18.27 5.23 Jun/2025
Incyte 14.77 134.3 Jun/2025
Ionis Pharmaceuticals 396.15 79.28 Sep/2022
Kangmei Pharma 126.35 9.9 Sep/2024
Knight Therapeutics 43.03 21.94 Dec/2021
Laboratorios Farma 20.04 0.23 Jun/2025
Malin Corporation 11.81 0.72 Jun/2023
Moderna 27.22 14.51 Jun/2023
Pharma Mar 70.33 15.83 Jun/2025
Qiagen NV 24.01 79.75 Jun/2025
Regeneron Pharmaceuticals 13.35 3.19 Jun/2025
Sarepta Therapeutics 27.27 0 Jun/2025
Sartorius 156.52 20.01 Jun/2025
Sino Biopharmaceutical 27.73 0.61 Jun/2024
United Therapeutics 11.45 0.02 Jun/2025
Vertex Pharmaceuticals 27.81 3.5 Jun/2025
Zz Pientze Pharmaceu 44.7 5.04 Jun/2025